Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Attendees at Diabetes: Secondary Complications, Regulation and Innovation, will hear Timothy Broke-Smith, Chief Operating Officer from Diabetology provide delegates with a unique insight into the oral delivery of insulin and other diabetes therapies. The address covered in the Clinical Development and Innovation session will draw from Axcess™ and Capsulin™ case study examples as well as discussing oral GLP-1.
Joining Diabetology at the 11th installment in the Diabetes series will be Glaxo SmithKline, Novo Nordisk, Celaris Biosystems, The International Diabetes Federation, Imperial College London and AstraZeneca.
Diabetes - 1st and 2nd October, 2013, London UK
For further details visit www.smi-online.co.uk/goto/2013diabetes-conference54.asp
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
Article adapted by Medical News Today from original press release. Source: SMi Group
Visit our Conferences category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Group, SMi. "Diabetes: secondary complications, regulation and innovation - 1st and 2nd October, 2013, London UK." Medical News Today. MediLexicon, Intl., 1 Aug. 2013. Web.
6 Dec. 2013. <http://www.medicalnewstoday.com/releases/264239>
Group, S. (2013, August 1). "Diabetes: secondary complications, regulation and innovation - 1st and 2nd October, 2013, London UK." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/264239.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.